Top Markets
Coin of the day
GBS Inc. GBS Inc.

GBS Inc.

GBS
Kedudukan dalam Saham #33710
Operating across North America and the Asia-Pacific region, GBS Inc.... Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film transistor designed for diabetes management that quantifies glucose levels directly from saliva. The company is also actively advancing a SARS-CoV-2 Biosensor, intended as a supplementary diagnostic tool to existing RNA virus detection tests, and is constructing a broad biosensor platform covering diagnostic modalities such as biochemistry, immunology, tumor markers, hormones, and nucleic acids. GBS Inc. maintains a research agreement with the Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic solutions. Founded in 2016 and headquartered in New York, New York, the company adopted its current name, GBS Inc., in September 2019, having previously operated as Glucose Biosensor Systems (Greater China) Holdings, Inc. It operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Harga Saham
$0.4732
Disegerakkan terakhir: 2022-10-26
Modal Pasaran
$7.05M
Perubahan (1 hari)
-0.03%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan GBS Inc. (GBS)

Kategori

Sejarah harga saham bagi GBS Inc. (GBS)
Harga penutupan tertinggi: $0.49 pada 2022-10-01

Harga penutupan terendah: $9.14 pada 2020-12-01
Sejarah harga saham GBS Inc. dari 2020 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2022 -69.81%
2021 -82.27%
2020 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$111.15 -15.64%
US
$339.00 -11.24%
US
$91.19 -1.97%
IE
$51.77 -49.83%
US
$91.49 16.90%
US